Eris Lifesciences has informed about the updation in the letter dated 14th August, 2017 regarding schedule of Analyst and Investor call pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.